Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade-Reference-Cited by-同舟云学术

Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade

Published:2000-07 Issue:1 Volume:140 Page:74-80
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Kereiakes Dean J.,Berkowitz Scott D.,Lincoff A.Michael,Tcheng James E.,Wolski Kathy,Achenbach Rob,Melsheimer Richard,Anderson Keaven,Califf Robert M.,Topol Eric J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference13 articles.

1. Thrombocytopenia with GP IIb/IIIa inhibitors: a meta-analysis;Giugliano;J Am Coll Cardiol,1998

2. Sustained platelet glycoprotein IIb/IIIa blockade with oral xemilofiban in 170 patients after coronary stent deployment;Kereiakes;Circulation,1997

3. Acute profound thrombocytopenia following c7E3 fab (abciximab) therapy;Berkowitz;Circulation,1997

4. Abciximab-associated profound thrombocytopenia: therapy with immunoglobulin and platelet transfusion;Kereiakes;Am J Cardiol,1996

5. Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization;Berkowitz;J Am Coll Cardiol,1998

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The investigation of thrombocytopenia after transcatheter occlusion of patent ductus arteriosus;BMC Cardiovascular Disorders;2024-01-18

2. Critical Analysis of Thrombocytopenia Associated With Glycoprotein IIb/IIIa Inhibitors and Potential Role of Zalunfiban, a Novel Small Molecule Glycoprotein Inhibitor, in Understanding the Mechanism(s);Journal of the American Heart Association;2023-12-19

3. Impact of Acquired Thrombocytopenia on Cardiovascular Outcomes in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis;Cardiovascular Revascularization Medicine;2021-06

4. Bivalirudin and sirolimus co-eluting coronary stent: Potential strategy for the prevention of stent thrombosis and restenosis;International Journal of Pharmaceutics;2021-05

5. Efficacy and safety of abciximab versus tirofiban in addition to ticagrelor in STEMI patients undergoing primary percutaneous intervention;Platelets;2021-02-09